To main content To main navigation

Marco Demaria

 Head of Cellular Senescence and Age-related Pathologies, Director Research Institute MoHAD Profile
Head of Cellular Senescence and Age-related Pathologies, Director Research Institute MoHAD
Contact information

Marco Demaria is a Full Professor of Cellular Aging at the Medical Faculty of the University of Groningen, Netherlands. He obtained his PhD at the University of Torino, Italy, studying the role of the transcription factor STAT3 as a master regulator of cancer cell survival and metabolism.  He joined the laboratory of prof. Judith Campisi at the Buck Institute for Research on Aging, California USA, in the summer of 2010 to navigate through the complex phenotypes of senescent cells. He also started to be interested in therapeutic approaches to target the negative aspect of senescent cells. He joined the University of Groningen and the European Research Institute for the Biology of Aging (ERIBA) in September 2015 as Tenure-track Professor and Group leader of the laboratory “Cellular Senescence and Age-related Pathologies”. His research is focused towards understanding the cell non-autonomous functions of senescent cells, including their roles in tissue repair, cancer and aging. The goal of his research group is to dissect positive and negative roles of cellular senescence in different physiological and pathological context. His laboratory is funded by several intramural and extramural agencies. Since 2021, dr Demaria is the President elect of the International Cell Senescence Association (ICSA). In 2018 he co-founded a start-up company, Cleara Biotech, devoted to develop anti-senescence drugs. Dr. Demaria also serves as Editor in-Chief for the open-access journal npj Aging. Since juli 2023, dr Demaria is the director of the research institute MoHAD: Mechanisms of Health, ​Ageing and Disease.
Large profile photo of M. Demaria

Roles